Benitec Biopharma INC DEF 14A proxy statements

Benitec Biopharma Inc. announced the appointment of Dr. Sharon Mates to its Board of Directors, increasing the board size to seven members.

Benitec Biopharma Inc. announced the details for its Annual Stockholder Meeting on December 1, 2025, including director elections and key proposals.

Benitec Biopharma Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on December 1, 2025, to vote on director elections, auditor ratification, and executive compensation.

Benitec Biopharma's Compensation Committee approved discretionary bonus payments for its Executive Chairman/CEO and Executive Director for their performance during the fiscal year ending June 30, 2024.

Benitec Biopharma is holding its annual stockholder meeting on December 4, 2024, to vote on director elections, ratification of the accounting firm, executive compensation, and authorization of preferred stock.

Benitec Biopharma Inc. will hold its annual shareholder meeting on December 4, 2024, to vote on director elections, ratification of the accounting firm, executive compensation, and an amendment to authorize additional preferred stock.

Benitec Biopharma is holding a special meeting on August 29, 2024, to seek stockholder approval for the potential issuance of shares upon warrant exercises and an amendment to the company's equity incentive plan.